Ardent Health Partners, LLC (NYSE:ARDT) Given Average Recommendation of "Buy" by Brokerages

Shares of Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) have been given a consensus recommendation of "Buy" by the twelve research firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $21.55.

ARDT has been the subject of a number of research analyst reports. JPMorgan Chase & Co. restated a "neutral" rating and set a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Bank of America lowered shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Morgan Stanley dropped their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, January 21st. KeyCorp started coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an "overweight" rating and a $24.00 target price on the stock. Finally, Leerink Partners boosted their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 12th.

Institutional Investors Weigh In On Ardent Health Partners

Institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $1,977,000. Jane Street Group LLC acquired a new stake in Ardent Health Partners during the 3rd quarter worth $567,000. Allspring Global Investments Holdings LLC acquired a new stake in Ardent Health Partners during the 3rd quarter worth $13,119,000. Goldentree Asset Management LP purchased a new position in Ardent Health Partners during the 3rd quarter worth $22,897,000. Finally, Barclays PLC acquired a new position in Ardent Health Partners in the third quarter valued at $385,000.

Ardent Health Partners Stock Performance

Shares of ARDT stock traded down $0.22 during trading on Monday, hitting $14.87. 135,193 shares of the stock traded hands, compared to its average volume of 353,250. Ardent Health Partners has a 52-week low of $13.63 and a 52-week high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm's fifty day moving average price is $15.80 and its 200-day moving average price is $17.08.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.10). The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.46 billion. Analysts anticipate that Ardent Health Partners will post 1.22 earnings per share for the current year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.